Introduction c-Abl is a predominantly nuclear tyrosine kinase containing N-terminal SH3, SH2 and kinase domains similar to Src (Pawson and Schlessinger, 1993) . The Cterminus harbors nuclear localization signals (Wen et al., 1996) as well as a DNA-binding and actin-binding domain (Kipreos and Wang, 1992; McWhirter and Wang, 1993) ; furthermore, it contains binding sites for the adaptor proteins Crk, Grb-2 and Nck (Ren et al., 1994) and a domain that associates with the C-terminal domain (CTD) of RNA polymerase II (Baskaran et al., 1996) . Nuclear c-Abl binds DNA (Miao and Wang, 1996) and supports other transcription factors through phosphorylation of the CTD (Baskaran et al., 1993) without being itself a transactivator. In dependence of cell context, c-Abl overexpression either inhibits or stimulates cell proliferation. Under physiological conditions, the kinase domain of a fraction of nuclear c-Abl is associated with and inhibited by the Cterminal pocket of the retinoblastoma tumor suppressor, Rb (Welch and Wang, 1993) . This inhibitory interaction is resolved upon hyperphosphorylation of Rb; as a consequence, c-Abl kinase becomes active in S phase of cell cycle. Conversely, c-Abl bound to Rb can inhibit the tumor suppressor function of Rb (Welch and Wang, 1995a) . The tightly regulated c-Abl tyrosine kinase is activated by DNA damage (Kharbanda et al., 1995; Liu et al., 1996a) except upon UV irradiation (Liu et al., 1996a) , and may contribute to a G1 cell cycle arrest in dependence of the p53 tumor suppressor (Yuan et al., 1996) . p53 can eciently eliminate damaged cells through the mediation of apoptosis (reviewed by Cox and Lane, 1995; Gottlieb and Oren, 1996) . This may involve transactivation of genes such as bax and IGF-BP3 (Miyashita and Reed, 1995; Buckbinder et al., 1995) ; however, these harbor binding sites with low anity for p53 (Friedlander et al., 1996) . We therefore hypothezised that the ecient activation of such genes may rely upon the presence of cooperating factors. Since c-Abl has been reported to associate with p53 and support transactivation (Goga et al., 1995) , and because cells do not tolerate constitutive overexpression of c-Abl (Sawyers et al., 1994) , we decided to study the eects of c-Abl and p53 on cell survival.
Results

c-Abl with intact kinase and PolII/actin-binding domains can mediate apoptosis independently of p53
A striking feature of both wild-type c-Abl and the fraction of transforming c-Abl that is localized in the nucleus, is their proliferation-suppressive eects (Sawyers et al., 1994; Wen et al., 1996) . This may be accompanied by cytotoxic eects (Wen et al., 1996) . Since p53 can mediate programmed cell death, for instance through the transactivation of apoptosis agonist such as bax (Miyashita and Reed, 1995) , and since c-Abl associates with p53 and supports transactivation (Goga et al., 1995) , it was interesting to examine whether c-Abl, alone or in the presence of p53, can provoke programmed cell death. Expression vectors that contain downstream of the CMV promoter either wild-type c-Abl or one of the mutants depicted in Figure 1a , were constructed and lipofected into p53-de®cient Hep3B hepatocarcinoma cells. Western blot analysis at 32 h after lipofection revealed that all proteins except the DPro1 mutant were produced to approximately equal levels ( Figure 1a ). DPro1 generated a slightly weaker signal, most likely because of its strong propensity to induce apoptosis. As we have documented earlier, Hep3B cells readily undergo apoptosis when p53 is expressed at low to moderate levels (Roemer and Mueller-Lantzsch, 1996) . We therefore employed, in a ®rst set of experiments, similar procedures to determine the fate of cells transfected with the c-Abl plasmids.
Subcon¯uent Hep3B cultures were cotransfected with 1 mg of a plasmid expressing the bacterial bgalactosidase (lacZ) gene from the CMV regulatory sequences plus 1 mg of either (i) empty CMV vector as control or (ii) vector producing a c-Abl variant. At 48 h after transfection, a subset of the cultures was stained for lacZ expression to identify transfected cells and simultaneously with DAPI to inspect for nuclear fragmentation and chromatin condensation characteristic of apoptotic cell death. Cultures transfected with control vector contained almost exclusively morphologically intact cells, whereas cultures transfected with wild-type c-Abl, and to a greater extent those that had received the DPro1 mutant, consistently contained lower numbers of surviving transfected cells plus approximately 20% rounded cells with fragmented nuclei. Furthermore, only cells transfected with Abl plasmids stained positive for nucleosomal DNA fragmentation in the TUNEL assay (Figure 1b) . Thus, wild-type c-Abl and c-Abl defective for DNAbinding can induce programmed cell death.
We next aimed to quantify the extent of apoptosis induced by c-Abl. This was most reliably accomplished by determining the number of surviving transfected cells, as rounded dead cells easily detach from the monolayer and are thus lost from the cultures. (The procedure has been successfully employed and described in detail by Liu et al., 1996b; Theis et al., 1997.) Figure 2a outlines the number of transfected surviving cells at dierent time points upon transfection of cultures with 1 mg of control plasmid or Abl plasmids. At early times after the beginning of transfection (32 h), c-Abl and, more pronounced, DPro1 caused cell loss through apoptosis. In contrast, tyrosine kinase mutant K290R and the Cterminal deletion mutant NED that no longer associates with RNA polymerase II and F-actin, failed to induce signi®cant cytopathic eects. At 80 h after transfection, up to 70% of the cells that had received c-Abl or DPro1 and 25% cells that had been transfected with a plasmid producing K290R, were eliminated from the cultures. NED was the least toxic mutant throughout the entire time course. Cotransfection of a vector producing the adenoviral apoptosis-antagonist E1B 19K protein together with c-Abl-producing plasmid overcame the cell loss, substantiating that this was the result of apoptotic death (Figure 2b ). Furthermore, inclusion in the transfections of 1 mg of plasmids that express either full-length Rb or the C-terminal pocket of Rb (SED) which associates with and inhibits c-Abl's kinase domain, partially rescued the cells from apoptosis ( Figure 2b ). Increasing the amounts of plasmids producing a c-Abl variant from 1 ± 4 mg resulted in stronger cytopathic responses (Figure 2c ). Under these conditions of strong overproduction, even the kinasedefective mutant K290R proved to be moderately cytotoxic. Mutant NED was less toxic. The loss of cells at 56 h after transfection with dierent quantities of cAbl-expressing plasmid re¯ected in a concomitant loss of b-galactosidase activity (Figure 2c ). At early times after transfection, prior to the onset of apoptosis, we were unable to detect any eect of c-Abl on the CMV promoter driving a CAT reporter gene (data not shown), precluding the reduction in b-gal activity to result from an eect of c-Abl on the CMV promoter driving lacZ. Finally and along the same line, we examined whether there is a decrease with time in Abl expression in transiently transfected cultures, which would be expected if Abl is cytocidal. Figure 2d shows the result of Western blot analyses of total cell protein prepared from cultures transfected with the dierent Abl variants. Note that relatively large plasmid quantities (10 mg) had Transfections were performed as in a but included, where indicated, 1 mg of plasmids producing the apoptosis antagonist E1B 19K, full-length Rb protein, or the C pocket fragment of Rb (SED). Care was taken to include in each transfection equal quantities of CMV promoter through the complementation with appropriate amounts of empty expression vector. (c) Cells were transfected as in a, except that 4 mg instead of 1 mg of eector plasmids were used. Cultures were analysed for surviving cells at 56 h after transfection. The right diagram outlines the bgalactosidase activity in total cell extracts prepared at 56 h after transfection with the indicated quantities of c-Abl plasmid. Error bars were derived from the average of three transfections. (d) Twenty-®ve mg of total protein extracts from cells transfected with 10 mg of plasmids producing the Abl variants were prepared at the indicated time points and analysed by Western blot using an anti-Abl polyclonal antibody at 1 : 200 dilution to be employed in order to be able to detect Abl protein in the Western blot procedure. Under these conditions of strong overproduction, mutants K290R and NED nevertheless accumulated to relatively high levels at 56 h after transfection, consistent with the lower toxicity of these proteins. However, the levels of K290R and NED decreased at later times, in accord with some toxicity of these mutants when strongly overexpressed. In contrast and in agreement with our cell survival studies, c-Abl and DPro1 failed to accumulate, and cAbl protein disappeared early from the transfected cultures. We conclude that c-Abl can mediate apoptosis in p53-negative Hep3B cells in the absence of DNAbinding. Ecient cell death induction requires a functional kinase domain and C-terminal PolII/actin interaction domain of c-Abl.
Since c-Abl can induce cell cycle arrest, it was possible that the lower numbers of transfected cells in the cultures that had received c-Abl plasmid relative to the control cultures was the result of cell proliferation arrest. However, several lines of evidence render this possibility very unlikely. First, apoptotic cell death could be detected in the cultures transfected with c-Abl but not in the controls (Figure 1b ). Second, cell loss was evident even at early times after transfection, before signi®cant cell proliferation took place. Third, apoptosis antagonist E1B 19K overcame the cell loss. Fourth, retinoblastoma protein which acts as a powerful suppressor of cell growth, failed to reduce the number of lacZ-positive cells (Figure 2b ). Finally, increasing quantities of c-Abl plasmid resulted in increasing cell loss. We therefore conclude that the reduced numbers of surviving transfected cells in the cultures treated with cAbl is the result of cell loss through apoptotic death.
Apoptosis by c-Abl is independent of the retinoblastoma protein
The association of c-Abl with Rb is inhibitory not only to c-Abl's kinase activity but also to functions of Rb (Welch and Wang, 1995a) . Furthermore, Rb is known to antagonize some forms of apoptosis (reviewed in Wang, 1997) . Although cell death by c-Abl depended upon the presence of the PolII/actin-binding C-terminal domain (Figure 2a) , it was conceivable that the cytopathic eects by c-Abl were mediated through the association with and inactivation of cellular Rb. To address this, we performed apoptosis studies in human Saos-2 osteosarcoma cells that are de®cient for both Rb and p53. Like Hep3B cells, Saos-2 cells rapidly underwent apoptosis upon transfection of 1 mg of plasmid producing wild-type c-Abl or the DPro1 mutant, but were refractory to the expression of NED. Again, kinase mutant K290R was less toxic than wildtype c-Abl, but induced more cell death than the NED mutant (Figure 3a) . Like in Hep3B cells, coexpression of Rb partially rescued cells from c-Abl mediated apoptosis (Figure 3a) . Furthermore, enhanced overproduction of the c-Abl variants upon transfection of 4 mg of plasmids resulted in an increased cell loss through apoptosis. NED was impaired but not entirely defective for apoptosis induction at this higher plasmid quantity (Figure 3b) . Finally, when we transfected Hep3B cells with a plasmid producing oncoprotein E7 that inactivates the tumor suppressor function of Rb by binding to its A/B pocket (Wang et al., 1994) , E7 failed to exert a measurable eect on cell survival (data not shown). These results indicate that the cytotoxicity caused by c-Abl overexpression is not mediated through the inhibition of Rb and is not restricted to one cell type.
c-Abl and p53 can cooperate to induce cell death p53 is a powerful mediator of programmed cell death in the p53-de®cient Hep3B cells (Roemer and MuellerLantzsch, 1996) . To study whether c-Abl and p53 can cooperate to provoke cytopathic eects, we analysed the survival of Hep3B cells upon transfection with (i) 0.2 mg p53 expression plasmid, (ii) 1 mg of plasmids expressing a c-Abl variant, or (iii) a combination of these constructs. The results are summarized in Figure  4a and enable us to draw two conclusions. First, p53 expressed from 0.2 mg and c-Abl produced from 1 mg of plasmids constructed from the same expression vector backbone, are approximately equally toxic. Second, p53 plus c-Abl and p53 plus DPro1 are more toxic than either protein alone. Thus, c-Abl and p53 can cooperate to mediate apoptosis. While the SED fragment of Rb alone suced to inhibit c-Ablmediated cell death (see Figure 2b ), apoptosis by p53 was only slightly aected by SED (Figure 4b ). However and in accord with previous ®ndings (Haupt et al., 1995; Haas-Koogan et al., 1995) , full-length Rb antagonized p53-mediated apoptosis eciently. This required the integrity of the A/B pocket of Rb since mutant D22 that lacks exon 22 or a protein with a mutation at amino acid 567 within the A/B pocket that is critical for protein interactions (Templeton et al., 1991) , failed to eciently counteract apoptosis ( Figure  4b ). In conjunction, this demonstrates that Rb can antagonize both c-Abl and p53-mediated cell death.
Many tumor cells express mutant forms of p53 in the absence of wild-type p53; furthermore, a gain-offunction of the mutant proteins has been implicated (for instance, Dittmer et al., 1993) . We therefore asked whether mutant p53 is able to antagonize apoptosis by Figure 3 Quantitation of the eects of c-Abl on the survival of Saos-2 cells that lack both Rb and p53. (a) Cells were transfected with 1 mg of the lacZ reporter plasmid plus 1 mg of a plasmid expressing one of the indicated Abl proteins or full-length Rb. The c-Abl transfection data are summarized as grey bars. Standard deviations were calculated from the data from four transfections. (b) Transfections of Saos-2 cells now included 4 mg of eector plasmids, but were otherwise performed as in a, and were analysed at 56 h after transfection c-Abl. As expected, cell death by wild-type p53 was overcome by coexpression of the p53 conformational mutant 175H or DNA-binding mutant 273H. In contrast, these mutants failed to exert a measurable eect on the cytotoxicity associated with c-Abl or DPro1 expression (Figure 4c) . Note that these studies were performed in Saos-2 cells. The reason is that Hep3B cultures consistently and unexpectedly responded with some apoptotic death to the production of the p53 mutants (KR, unpublished data). In conclusion, c-Abl can provoke death in tumor cells even in the presence of mutant p53.
c-Abl fails to super-transactivate p53-responsive regulatory sequences placed on plasmids
It has been reported that c-Abl with intact kinase, DNAbinding, and PolII-binding domains can super-transactivate the fos gene promoter (Baskaran et al., 1996) .
Others have documented that super-transactivation by c-Abl of arti®cial p53-responsive promoters containing copies of the ribosomal gene cluster p53 DNA binding site, was not dependent on kinase function (Goga et al., 1995) . Since p53 may mediate apoptosis at least in part through the transactivation of cell death genes such as bax and IGF-BP3, yet these harbor low-anity binding sites for p53 (Friedlander et al., 1996) , it was thus possible that c-Abl and p53 cooperate to transactivate genes. To test this, we performed transfections with (i) plasmid PG13-CAT containing an arti®cial p53-responsive promoter placed upstream of a CAT gene, or (ii) pbax-CAT, harboring a CAT gene driven by the bax promoter. Only 0.01 mg of p53 plasmid stimulated signi®cant CAT production in Hep3B and Saos-3 cells at 48 h after transfection. c-Abl plasmids were cotransfected at amounts sucient to overproduce the protein at low to moderate levels (0.1 mg). At higher plasmid quantities, results were obscured by massive apoptotic Eect of mutant p53 on apoptosis by c-Abl and wild-type p53. These studies were performed in Saos-2 cells (see Results for details). Cells were transfected as above, using 0.2 mg of wild-type p53 plasmid and 1 mg of the c-Abl plasmids as indicated. In addition, 1 mg of vectors expressing p53 mutants 175H or 273H were included in some transfections. Cells were analysed later after transfection (at 56 h) because Saos-2 cells were less sensitive to apoptosis by p53 than Hep3B cells. (d) Eect of c-Abl and p53 on the stimulation of CAT activity from the bax gene promoter. Transient transfections with 4 mg of pbax-CAT and either 0.01 mg of p53 plasmid, 0.1 mg of a c-Abl eector, or a combination of these were analysed at 48 h after transfection cell death. In contrast to previous ®ndings (Goga et al., 1995) , we were not able to detect any consistent and signi®cant eect of c-Abl or its mutants on the transactivation by p53 of either PG13-CAT or pbax-CAT. Figure 4d summarizes the data obtained with pbax-CAT in Hep3B cells and Saos-2 cells de®cient for the c-Abl-inhibiting Rb protein. The large standard deviations likely re¯ect cooperative eects of p53 and cAbl on cell survival. We conclude that the increased cytotoxicity induced by p53 plus c-Abl is not correlated with a measurable super-transactivation of the bax promoter placed on a plasmid.
Discussion
The precise function of the c-Abl tyrosine kinase and its possible connection with the Rb and p53 tumor suppressors is obscure. Previous studies have documented that c-Abl's kinase is activated in response to genotoxic stress except UV irradiation (Kharbanda et al., 1995; Liu et al., 1996a) . However, the result of this activation is controversial and may depend on cell context. For instance, DNA damage has been reported to induce complex formation between c-Abl and p53 and a subsequent downregulation of G1 cyclin-dependent kinases with the consequence of a G1 cell cycle arrest (Yuan et al., 1996) . Other ®ndings indicate that c-Abl activation is con®ned to the S phase of cell cycle and render unlikely that kinaseactive c-Abl eects the G1/S transition (Liu et al., 1996a) . However, it seems to be undisputed that cAbl's kinase is activated upon genotoxic stress and that most if not all known phenotypes induced by wild-type or transforming Abl depend upon a functional kinase.
While the role of c-Abl in the damage-induced G1 response remains to be elucidated, it is known for some time that overexpression of wild-type c-Abl and remarkably, also of the transforming mutants is not tolerated (Ziegler et al., 1981; Sawyers et al., 1994) . Evidence exists that the mechanisms used by wild-type and transforming Abl to inhibit cell growth are dierent. While large quantities of transforming Abl seem to be mostly toxic (Sawyers et al., 1994) , the wildtype protein may provoke a G1 arrest in at least a portion of the cells that overproduce it (Yuan et al., 1996) . Overexpressed wild-type or transforming Abl can inhibit colony growth only when localized in the nucleus and active as a tyrosine kinase (Wen et al., 1996) . However, although c-Abl is predominantly nuclear, it is usually kinase-inactive. In contrast, transforming Abl is permanently kinase-active but almost exclusively cytoplasmic. Overproduction of wild-type c-Abl may thus result in nuclear c-Abl that is kinase-active, for instance upon the titration of inhibitory Rb. In contrast, overproduction of transforming Abl may simply increase the fraction of protein that is localized in the nucleus. The consequence of either would be colony growth inhibition. The data presented here indicate that at least part of the cytostatic eects of kinase-intact c-Abl is the result of programmed cell death and that apoptosis mediation, in contrast to the G1 arrest (Wen et al., 1996; Yuan et al., 1996; Goga et al., 1995) , does not need the presence of p53.
We have documented that the deletion of the Cterminus of c-Abl downstream of the DNA-binding domain and not involving the nuclear localization signals, greatly diminishes cytotoxicity. This region of the protein has been characterized as the domain that associates with the CTD of RNA polymerase II and Factin (Van Etten et al., 1994; Baskaran et al., 1996) . It is unclear at present whether the association with PolII/actin or some other function of the C-terminus is involved in apoptosis. The facts that (i) the SH2 domain of c-Abl has a role in the interaction with PolII (Duyster et al., 1995) and (ii), SH2 is also important for the ecient inhibition of cell colony-formation by c-Abl (Sawyers et al., 1994) , are in accord with a function for PolII in c-Abl-mediated cell death. On the other hand, interaction between c-Abl and PolII in vivo seems to require c-Abl's DNA binding domain (Baskaran et al., 1996) . As we have shown, DNA binding is completely dispensable for apoptosis induction. In contrast, DNA binding seems to be essential for the ecient cell cycle arrest upon c-Abl expression (Wen et al., 1996; Yuan et al., 1996) .
Ecient induction of cell death (this study) or G1 arrest (Yuan et al., 1996) by c-Abl requires a functional kinase. This was underscored by the fact that the C pocket fragment of Rb that associates with and inhibits c-Abl's kinase activity (Welch and Wang, 1993) , could partially overcome apoptosis induction. However, at this point it was not excluded that part of c-Abl's toxicity was the result of the inactivation of Rb functions. Rb can eciently antagonize some forms of apoptosis (Wang, 1997) and the extreme C-terminus of Rb (not involving c-Abl binding) is cleaved o during apoptosis by the cysteine protease Ced-3/ICE (JaÈ nicke et al., 1996) . Moreover, examples of functions of Rb that can be blocked by c-Abl do indeed exist (Welch and Wang, 1995a) . Since Saos-2 cells that lack Rb and p53 readily underwent apoptosis by c-Abl, and inhibition of Rb in Hep3B cells through the E7 oncoprotein did not per se induce cytopathic eects, we conclude that apoptosis is not mediated through the inhibition of Rb functions. Nevertheless, Rb antagonized apoptosis by both p53 and c-Abl eciently. In the csae of p53 and in accord with previous observations (Haupt et al., 1995; Haas-Koogan et al., 1995) , this required the A/B pocket of Rb and is likely to involve binding to and inhibition of the transcription factor E2F-1 (Hiebert et al., 1995) . In the case of c-Abl, the presence of an intact C pocket domain of Rb, i.e. inhibition of the tyrosine kinase function was sucient to increase cell survival.
c-Abl induces apoptosis under conditions of overproduction. However, there are no precedents for c-Abl being overexpressed under physiological conditions. Can endogenous cellular Abl act as a determinator of cell survival, perhaps in cooperation with p53? In contrast to previous observations (Goga et al., 1995) , we found no evidence for c-Abl supporting transactivation by p53. One reason for this discrepancy might be the smaller quantities of c-Abl expression plasmids used in this study, primarily to avoid large-scale cell loss. However, forms of cooperation between p53 and c-Abl other than super-transactivation may be relevant. For instance, p53 might mask the DNA-binding domain of c-Abl through direct interaction (Goga et al., 1995) . We have shown that the DPro1 mutant defective for DNA binding is a more potent mediator of cell death than wild-type c-Abl. It is furthermore conceivable that p53 activates c-Abl's kinase via the interaction between the SH3-binding Pro-X-X-Pro motifs of p53 and c-Abl's SH3 domain. The SH3 domain motifs of p53 have recently been shown to be important for the ecient induction of apoptosis by p53 (Walker and Levine, 1996; Sakamuro et al., 1997) as well as for the transactivation-independent growth arrest by p53 induced by the growth arrest speci®c (Gas-1) protein (Ruaro et al., 1997) . Although there is, at present, no evidence that c-abl sequences are frequently mutated in tumor cells, it is remarkable that the wild-type c-abl allele is often lost in late stages of Philadelphia chromosome leukemias harboring a bcr-abl allele. Furthermore and in accord with the data presented here, very recent studies have shown that DNA-damage induced apoptosis can be mediated by physiological levels of endogenous c-Abl and in the absence of p53 (Yuan et al., 1997) . The mechanisms of apoptosis induction by c-Abl deserves further attention.
Materials and methods
Cell culture, transfections and reporter assays
Hep3B and Saos-2 cells were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal calf serum in a humidi®ed 7% CO 2 atmosphere. At 24 h prior to transfection, cells were seeded on 35 mm dishes to 50% con¯uency. The CaPO 4 -coprecipitation method was employed to transfect equal quantities of promoters and total DNA as described (Roemer and Mueller-Lantzsch, 1996) . The precipitate was left on the cultures for 7 h. For b-galactosidase stain, cells were ®xed with 1.25% glutaraldehyde for 15 min at the time points indicated in the ®gures. Transfected cells were identi®ed by staining for 4 h at 378C with the chromogenic substances 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-gal; Boehringer Mannheim); for the determination of CAT or b-galactosidase activity, protein extracts were prepared and subjected either to non-chromatographic CAT or liquid bgal assays as previously described (Roemer and MuellerLantzsch, 1996) .
Plasmid constructs
All sequences were cloned into expression vector pCMVpA that served as control plasmid and contains the CMV promoter/enhancer and the SV40 polyadenylation site. The genes encoding wild-type c-Abl, tyrosine kinase mutant K290R, and the DPro1 mutant defective for DNA-binding were described earlier (Goga et al., 1995) . Mutant NED was constructed by deletion of the C-terminal 105 amino acids through cleavage at the NarI site at position 3130. Plasmid pbax-CAT contains the human bax gene promoter from position 7965 to 7318 in the 5' untranslated region, placed upstream of a CAT reporter gene. Plasmids pCMVRb, pCMV-SED, pCMV-D22, and pCMV-567L were constructed by insertion into pCMV-pA of either fulllength Rb or one of the Rb mutants, SED (Welch and Wang, 1995b) , D22, or 567L (Templeton et al., 1991) . Plasmids pCMV-175 and pCMV-273 result from the cloning of p53 mutants 175H or 273H into pCMV-pA. Constructs pCMV-hwt53 and PG13-CAT were described in (Roemer and Mueller-Lantzsch, 1996; Kern et al., 1992) .
Cell death studies
For chromatin condensation/nuclear fragmentation assay, cells were grown and transfected on coverslips. Transfected cells were identi®ed by staining with X-gal as above; nuclei were then stained with 4,6-diamidino-2-phenylindole (DAPI; Sigma) at 1 mg/ml. Endonucleolytic cleavage of DNA in transfected cells was studied by TdT-mediated dUTP nick end-labelling (TUNEL) using the in situ cell death detection kit from Boehringer Mannheim. In this assay, DNA strand breaks were labelled with¯uorescein and detected with an anti-¯uorescein antibody conjugated with horse-raddish peroxidase. Transfected surviving cells were quanti®ed by determining the number of bgalactosidase-positive cells in 20 microscopic ®elds per transfection with 30 ± 50 transfected cells per ®eld, as previously described (Liu et al., 1996b; Theis et al., 1997) .
Western blotting
Protein extracts from cells lipofected with DOSPER according to the manufacturer's protocol (Boehringer Mannheim) were prepared at 32 h or the indicated times after lipofection following standard procedures. Total proteins (25 mg) were separated on a standard SDS/8% polyacrylamide gel and transferred to Immobilon-P membrane (Millipore). The membrane was incubated with c-Abl polyclonal antibody Ab-1 (Calbiochem) at a 1 : 200 dilution and the signal was revealed by the ECL chemiluminescence detection kit (Amersham).
